1. Market Research
  2. > Biotechnology Market Trends
Western Blotting Market by Product, Application, End User - Global Forecasts to 2021

Western Blotting Market: Global Forecasts until 2021

  • November 2016
  • 171 pages
  • ID: 4339709
In this report:
North America is expected to account for the largest share of ~##% in 2016, at a CAGR of ##.##% during the forecast period This growth is mainly attributed to increasing diagnosis of HIV infections and Lyme disease to propel the market in the U.S.; rise in research funding and increasing production of genetically modified crops in the U.S.; HIV vaccine initiative in Canada; and intensity of pharmaceutical clinical trials in Canada.
Furthermore, the R&D investment by these companies in 2014 was USD ## million (EUR ##.## million) (an increase of ##.##% over the previous year) (Source: asebio).

Summary

Table of Contents

Search Inside

The western blotting market is estimated to grow $730.70M by 2021 from $574.80M in 2016, at a Compound annual growth rate of 4.90 percent in the next five years (2016 to 2021).

The western blotting market is undergoing a significant transformation, with the automation of blotting systems and imagers. As well, it is one of the most basic technologies for the separation of proteins and is seen at almost every protein research laboratories. The increase of this market is mainly influenced by the dynamics of the protein research sectors.

The growing number of research activities and R&D spending by pharmaceutical and biotechnology firms, growing prevalence of HIV/AIDS, increasing proteomics market, the increasing number of industry-academic research collaborations, growing demand for personalized medicine, and latest product launches are some factors projected to drive the increase of the overall western blotting market in the next years. On the other hand, emergence of alternative technologies is anticipated to restrain the increase of the market. Nevertheless, automation in western blotting instruments is anticipated to pose lucrative opportunities for the western blotting market. Additionally, stringent regulations and requirement of high procedural efficiency for accurate results are likely to challenge the western blotting market in the next years.

In 2016, North America continent is forecasted to account for the biggest share of the overall western blotting market, succeeded by Europe (EU), Asia Pacific (APAC), and the Rest of the globe. North America's big share is assigned to the growing prevalence of HIV and Lyme disease, U.S. -China collaborative program for biomedical research, increase in research funding & rising production of genetically modified crops in the U.S.A, HIV vaccine initiative, and Growing intensity of pharmaceutical and biopharmaceutical clinical research in Canada (CA). In the next years, the western blotting market is anticipated to witness the highest increase in the Asia Pacific (APAC) area, with emphasis on India (IN), China (CN), and Japan (JP). This can be connected to Elements such as presence of bioclusters in China (CN) and India (IN), outsourcing of research activity in China (CN), growing government interest in biomedical & biotechnology sector in China (CN), government actions supported by funding in Japan (JP), increasing pharmaceutical & biotechnology market in Japan (JP), increasing pharmaceutical sector backed by government funding in India (IN), and increasing funding for agriculture research in India (IN).

The market witnesses high competitive intensity, as there are various companies of different size with similar product offerings. These firms embrace different strategies (business developments; recent product launches; marketing and promotion; strategic agreements, collaborations, alliances, and joint ventures (JV); funding; acquisitions; and product enhancement to rise their market shares and establish a strong foothold in the overall market.

Comprehensive interviews were managed with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from numerous main institutions operating in the adaptive security market place.

- By Company Type: Tier 1: 50.0 percent, Tier 2: 35.0 percent, Tier 3: 15.0 percent

- By Designation: Director Level: 53.0 percent, C-Level: 28.0 percent, Others: 19.0 percent

- By area: North america (NA): 35.0 percent, Europe: 25.0 percent, APAC: 28.0 percent, ROW: 12.0 percent

The market research includes the study of top players offering western blotting including BioRad (NYSE:BIO), Thermo Fisher Scientific (NYSE:TMO), GE Healthcare (GE subsidiary), Advasta, Incorporated, LI-COR Biosciences, PerkinElmer (NYSE:PKI), Bio-Techne Corporation, Merck KGaA (MKGA), F. Hoffmann-La Roche Ltd., and Cell Signaling Technology, Incorporated.

Segment Research

The industry report offers a picture on western blotting instruments and consumables across various applications and territories. It aims at evaluating the market value and upcoming growth potential of this market across distinct segments including product, application, end-user, and localities. Moreover, the study also comprises a detailed competitive analysis of the top players in the sector together with their company descriptions, recent evolutions, and key industries strategies.

Main highlights

The analysis will facilitate the market top players/new sector entrants in this sector by providing them the closest approximations of the revenue numbers for the global western blotting market and the sub-segments. This industry report will facilitate partners to better find out the competitor overview and obtain additional insights to better option their businesses and make suitable go-to-market approaches. The market research also benefits the partners to comprehend the pulse of the sector and offers them information on main market drivers, market restraints, opportunities, and alternatives.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Rheumatoid - Inflammatory Diseases Markers Tests - Medical Devices Pipeline Assessment, 2017

Rheumatoid - Inflammatory Diseases Markers Tests - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • September 2017
  • by GlobalData

Rheumatoid - Inflammatory Diseases Markers Tests - Medical Devices Pipeline Assessment, 2017SummaryGlobalData’s Medical Devices sector report, “Rheumatoid - Inflammatory Diseases Markers Tests - Medical ...

Melanoma Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Melanoma Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • October 2017
  • by GlobalData

Melanoma Diagnostic Tests - Medical Devices Pipeline Assessment, 2017SummaryGlobalData’s Medical Devices sector report, “Melanoma Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides ...

United States Genetic Testing Market Outlook to 2024

Genetic Testing in United States to 2024

  • $ 4995
  • Industry report
  • November 2017
  • by GlobalData

United States Genetic Testing Market Outlook to 2024SummaryGlobalData’s new report, United States Genetic Testing Market Outlook to 2024, provides key market data on the United States Genetic Testing ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.